NGNE
Neurogen Corp
Biopharmaceutical company focused on drug discovery for neurological and psychiatric disorders
CUSIP: 64124E106HealthcareUS1 holder
Total Value
$1.80M
Total Shares
496.7K
Net Share Change
+496.7K
Activity
1 buying
Investor
Value
Shares
Weight
Change
